Matthew D. Rousculp

1.9k total citations
57 papers, 1.4k citations indexed

About

Matthew D. Rousculp is a scholar working on Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Matthew D. Rousculp has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Health, 16 papers in Infectious Diseases and 16 papers in Epidemiology. Recurrent topics in Matthew D. Rousculp's work include Vaccine Coverage and Hesitancy (19 papers), SARS-CoV-2 and COVID-19 Research (13 papers) and Influenza Virus Research Studies (13 papers). Matthew D. Rousculp is often cited by papers focused on Vaccine Coverage and Hesitancy (19 papers), SARS-CoV-2 and COVID-19 Research (13 papers) and Influenza Virus Research Studies (13 papers). Matthew D. Rousculp collaborates with scholars based in United States, United Kingdom and Canada. Matthew D. Rousculp's co-authors include Parthiv J. Mahadevia, Shaohung Wang, Stacey R. Long, Seth Toback, Harry F. Hull, John Cawley, Kristin L. Nichol, Keith L. Davis, Emuella Flood and Lucinda Orsini and has published in prestigious journals such as The Journal of Infectious Diseases, Journal of the American Geriatrics Society and Diabetologia.

In The Last Decade

Matthew D. Rousculp

55 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew D. Rousculp United States 23 493 325 170 147 129 57 1.4k
Pablo Emilio Verde Germany 26 194 0.4× 221 0.7× 62 0.4× 66 0.4× 45 0.3× 82 1.9k
Amir Kasaeian Iran 25 178 0.4× 70 0.2× 125 0.7× 92 0.6× 13 0.1× 141 1.6k
Alcione Miranda dos Santos Brazil 22 181 0.4× 67 0.2× 179 1.1× 73 0.5× 41 0.3× 127 1.5k
Peng Bai China 16 221 0.4× 68 0.2× 91 0.5× 136 0.9× 42 0.3× 52 2.1k
Kostas Athanasakis Greece 15 127 0.3× 83 0.3× 45 0.3× 85 0.6× 28 0.2× 132 808
Jørgen Vinsløv Hansen Denmark 24 149 0.3× 210 0.6× 285 1.7× 27 0.2× 55 0.4× 55 2.2k
Neda Mehrdad Iran 22 100 0.2× 116 0.4× 160 0.9× 82 0.6× 119 0.9× 110 1.4k
Judith D. Bebchuk United States 22 115 0.2× 39 0.1× 351 2.1× 14 0.1× 90 0.7× 48 1.9k
Marien González‐Lorenzo Italy 19 270 0.5× 52 0.2× 66 0.4× 24 0.2× 21 0.2× 42 1.6k
Femke Atsma Netherlands 23 124 0.3× 77 0.2× 163 1.0× 359 2.4× 17 0.1× 85 2.4k

Countries citing papers authored by Matthew D. Rousculp

Since Specialization
Citations

This map shows the geographic impact of Matthew D. Rousculp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Rousculp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Rousculp more than expected).

Fields of papers citing papers by Matthew D. Rousculp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew D. Rousculp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Rousculp. The network helps show where Matthew D. Rousculp may publish in the future.

Co-authorship network of co-authors of Matthew D. Rousculp

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew D. Rousculp. A scholar is included among the top collaborators of Matthew D. Rousculp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew D. Rousculp. Matthew D. Rousculp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choe, Seung‐Ah, et al.. (2025). Real-world effectiveness of NVX-CoV2373 and BNT162b2 mRNA COVID-19 vaccination in South Korea. Vaccine. 62. 127496–127496.
2.
Rousculp, Matthew D., et al.. (2025). Efficacy, immunogenicity, and safety of the Novavax COVID-19 vaccine in immunocompromised patients: A targeted literature review. Vaccine. 49. 126777–126777. 1 indexed citations
3.
Choe, Seung‐Ah, et al.. (2024). Relative effectiveness of homologous NVX-CoV2373 and BNT162b2 COVID-19 vaccinations in South Korea. Vaccine. 43(Pt 1). 126503–126503. 1 indexed citations
4.
Rousculp, Matthew D., Kelly Hollis, Ryan Ziemiecki, et al.. (2024). Reactogenicity Differences between Adjuvanted, Protein-Based and Messenger Ribonucleic Acid (mRNA)-Based COVID-19 Vaccines. Vaccines. 12(7). 802–802. 2 indexed citations
5.
Salisbury, David, Jeffrey V. Lazarus, Nancy M. Waite, et al.. (2024). COVID-19 Vaccine Preferences in General Populations in Canada, Germany, the United Kingdom, and the United States: Discrete Choice Experiment. JMIR Public Health and Surveillance. 10. e57242–e57242. 2 indexed citations
6.
7.
8.
Lewis, Hannah B, Matthew D. Rousculp, Clara Lehmann, et al.. (2023). MSR21 Methodological Aspects of a COVID-19 Vaccine Discrete Choice Experiment Survey in Canada, Germany, UK, and US General Populations. Value in Health. 26(12). S397–S397. 1 indexed citations
9.
Laliberté, François, et al.. (2022). Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States. Therapeutic Advances in Respiratory Disease. 16. 2673696325–2673696325. 9 indexed citations
10.
Johnston, Stephen S., et al.. (2010). Employees' willingness to pay to prevent influenza.. PubMed. 16(8). e205–14. 10 indexed citations
11.
Flood, Emuella, Stan L. Block, Matthew C. Hall, et al.. (2010). Children's Perceptions of Influenza Illness and Preferences for Influenza Vaccine. Journal of Pediatric Health Care. 25(3). 171–179. 13 indexed citations
12.
Cawley, John, Harry F. Hull, & Matthew D. Rousculp. (2010). Strategies for Implementing School-Located Influenza Vaccination of Children: A Systematic Literature Review. Journal of School Health. 80(4). 167–175. 79 indexed citations
13.
Rousculp, Matthew D., et al.. (2010). Attending Work While Sick: Implication of Flexible Sick Leave Policies. Journal of Occupational and Environmental Medicine. 52(10). 1009–1013. 23 indexed citations
14.
Meadows, Eric S., et al.. (2007). Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia. BMC Women s Health. 7(1). 6–6. 28 indexed citations
15.
Rubino, Annalisa, et al.. (2007). Diagnosis of diabetic peripheral neuropathy among patients with type 1 and type 2 diabetes in France, Italy, Spain, and the United Kingdom. Primary care diabetes. 1(3). 129–134. 28 indexed citations
16.
Rousculp, Matthew D., Stacey R. Long, Shaohung Wang, Michael J. Schoenfeld, & Eric S. Meadows. (2007). Economic Burden of Osteoporosis-Related Fractures in Medicaid. Value in Health. 10(2). 144–152. 43 indexed citations
17.
Rousculp, Matthew D., et al.. (2007). PDB33 VALIDATION OF THE 25-ITEM NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE (VFQ-25) IN PATIENTS WITH DIABETIC RETINOPATHY. Value in Health. 10(3). A69–A70. 3 indexed citations
18.
Orsini, Lucinda, Matthew D. Rousculp, Stacey R. Long, & Shaohung Wang. (2004). Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures. Osteoporosis International. 16(4). 359–371. 89 indexed citations
19.
McGwin, Gerald, Victoria Chapman, Jonathan M. Curtis, & Matthew D. Rousculp. (1999). Fire Fatalities in Older People. Journal of the American Geriatrics Society. 47(11). 1307–1311. 10 indexed citations
20.
Fine, Philip R., et al.. (1998). Are Newspapers a Viable Source for Intentional Injury Surveillance Data?. Southern Medical Journal. 91(3). 234–242. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pablo Emilio Verde Breakdown of academic impact, for papers by Amir Kasaeian Breakdown of academic impact, for papers by Alcione Miranda dos Santos Breakdown of academic impact, for papers by Peng Bai Breakdown of academic impact, for papers by Kostas Athanasakis Breakdown of academic impact, for papers by Jørgen Vinsløv Hansen Breakdown of academic impact, for papers by Neda Mehrdad Breakdown of academic impact, for papers by Judith D. Bebchuk Breakdown of academic impact, for papers by Marien González‐Lorenzo Breakdown of academic impact, for papers by Femke Atsma
Rankless by CCL
2026